Power Law company profile

Oncodesign Precision Medicine

Biotech & Life Sciences · Dijon, France · Founded 1995 · IPO 2014 Colt

Conducts research and development work on new therapeutic and diagnostic tools

Valuation

$113M

Market cap · 2026

Revenue

$57M

Latest reported FY

EBITDA

$3.3M

Latest reported FY

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

3 investors on Oncodesign Precision Medicine's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 3 investors entered at this stage

EIT Health

Banque de Vizille

Avenir Entreprises Gestion

Global footprint

Where Oncodesign Precision Medicine has talent and traffic

AI talent share

7.1% of workforce is AI talent
(1 of 14 staff)

Core AI17.14%

Other AI00%

Non-AI workforce1392.86%

Workforce by country

🇫🇷 France · Dijon HQ

Book a demo for the full country breakdown

Web traffic by country

1.4K monthly visits
across markets

🇫🇷 France78.6%

🇧🇪 Belgium21.4%

Top 2 markets shown

Market sentiment

What the market is saying about Oncodesign Precision Medicine

An AI-synthesized read of the highest-engagement posts about Oncodesign Precision Medicine on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Oncodesign Precision Medicine on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles